Clinical Trials Completed For Human Bird Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
China's self-developed bird flu vaccine intended for humans has successfully completed Phase III clinical trials. China's State FDA has now approved the vaccine for production. Eight patients infected with highly pathogenic avian influenza H5N1 received treatment with the new vaccine in late December, and it It has been successful in three of them so far in China. (Click here for more